Notice for 30th Annual General Meeting to be held on 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited (BSE: 531458) has called its 30th AGM on Tuesday, 30th September 2025 at 11:30 AM via video conference. Ordinary business includes adopting FY25 audited financials, reappointing Mr. Ghanshyam Dhananjay Gavali (retiring by rotation), and appointing M/s Sunit M Chhatbar & Co as statutory auditor for a 5-year term ending with the 2030 AGM. Special business covers filling the casual auditor vacancy caused by the resignation of M/s Nahar V. & Co, changing Mr. Gavali's designation from Executive Director to Managing Director for 5 years, and regularising Mr. Yash Arun Chaudhary as Non-Executive Non-Independent Director. The most consequential proposals are: changing the company name to 'Boston Commerce Limited', overhauling the object clause to add IT/software, agriculture, real estate and e-commerce as new business lines, adopting new MOA and AOA, raising the borrowing limit to Rs. 50 crores, and authorising loans/guarantees up to Rs. 50 crores under Section 186. Remote e-voting runs from 27th to 29th September 2025, with the cut-off date set as 23rd September 2025.
This AGM is effectively a corporate transformation vote — shareholders are being asked to approve a name change, a radical pivot in business objects away from bio-systems into trading, IT, agriculture and real estate, and a major increase in borrowing and investment capacity to Rs. 50 crores each. Approval would fundamentally change the company's identity and risk profile, while rejection could stall the management's restructuring plans.